We go beyond analytical testing to support your entire program—from early development through regulatory submission and commercial readiness. 

Working with controlled psychedelic substances presents unique challenges—strict regulatory oversight, licensing requirements, and the need for precise, defensible analytical data. Any gaps in compliance or testing accuracy can delay research, disrupt development timelines, or jeopardise regulatory approvals. Our Toronto laboratory provides Health Canada–authorised GMP analytical testing for controlled psychedelics.

Licensed. Compliant. Scientifically robust. 

Our BPT laboratories hold a Health Canada Dealer’s Licence, permitting us to legally handle and test controlled substances, including:

• DMT
• Ibogaine 
• LSD
• MDMA
• Mescaline
• Psilocybin and Psilocin

These substances are regulated under Schedule III of the Controlled Drugs and Substances Act (CDSA), requiring specialised expertise, secure handling, and full regulatory adherence. 

Comprehensive analytical capabilities

We provide a full suite of testing services tailored to psychedelic and controlled drug products:

• Impurity and degradation profiling
• Elemental impurities testing
• Residual solvent analysis
• Stability studies to support shelf life and storage conditions

A partner who understands the regulatory landscape

You need a partner who can navigate complex compliance frameworks while delivering accurate, reliable data. Our experts work closely with you to:

• Ensure full compliance with Health Canada requirements
• Streamline licensing and regulatory processes
• Mitigate risk when handling controlled substances
• Maintain data integrity for submissions and audits

Get in touch

With deep scientific expertise and authorised capabilities, we partner with you to advance psychedelic and controlled drug programmes safely, compliantly, and efficiently.

Contact us